Recruiting studies: Kidney Transplant Tolerance

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Phase 1/Phase 2 · 1 location(s) · Jeffrey Veale, MD · NCT03707262 Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507 Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
Phase 2 · 8 location(s) · TolerogenixX GmbH · NCT05365672 Kidney Graft Tolerance KTOL
Phase N/A · 1 location(s) · Nantes University Hospital · NCT06271343 Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.
Phase 1 · 1 location(s) · Stephan Busque · NCT03591302 TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantat
Phase 1 · 2 location(s) · Stanford University · NCT03943238 Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Phase 1/Phase 2 · 2 location(s) · Midhat H. Abdulreda · NCT02846571 Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction
Phase 2 · 1 location(s) · Rabin Medical Center · NCT05086003 Tolerance Through Mixed Chimerism (Sip-Tego)
EARLY_Phase 1 · 1 location(s) · Tatsuo Kawai, MD, PhD · NCT06972069

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.